Alnylam Pharmaceuticals, Inc.
Serpina1 siRNAs: compositions of matter and methods of treatment
Last updated:
Abstract:
The technology described herein relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the Serpina 1 gene, and methods of using such dsRNA compositions to inhibit expression of Serpina 1.
Status:
Grant
Type:
Utility
Filling date:
17 Jul 2019
Issue date:
2 Mar 2021